Anna Tenstam-Lundvall
Corporate Officer/Principal at ColBar LifeScience Ltd.
Profile
Anna Tenstam-Lundvall is Executive Vice President of Commercialization for ColBar LifeScience Ltd.
Prior to joining ColBar, she was Vice President and Global Business Unit Director of Q-Med AB.
She held various positions at Bristol-Myers Squibb.
Lederle, Cyanamid and Pharmacia.
Ms. Tenstam-Lundvall received a B.Sc.
degree in Biomedical engineering from Uppsala University.
Anna Tenstam-Lundvall active positions
| Companies | Position | Start |
|---|---|---|
ColBar LifeScience Ltd.
 ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Corporate Officer/Principal | - |
Training of Anna Tenstam-Lundvall
| University of Uppsala | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
ColBar LifeScience Ltd.
ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Health Technology |
- Stock Market
- Insiders
- Anna Tenstam-Lundvall
